These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37056815)

  • 1. Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma.
    Li G; Atiq W; Hashmi MF; Ibrahim SS; Al Abdulsalam KA; Kadham MJ; Al-Azzawi AKJ; Aufy M; Abdel-Maksoud MA
    Am J Transl Res; 2023; 15(3):1550-1568. PubMed ID: 37056815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering cervical cancer-associated biomarkers by integrated multi-omics approach.
    Li X; Abdel-Maksoud MA; Iqbal I; Mubarak A; Farrag MA; Haris M; Alghamdi S; Ain QU; Almekhlafi S
    Am J Transl Res; 2022; 14(12):8843-8861. PubMed ID: 36628250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis of microarray data from the GEO database to identify the candidate genes linked to poor prognosis in lung adenocarcinoma.
    Liu X; Li L; Xie X; Zhuang D; Hu C
    Technol Health Care; 2023; 31(2):579-592. PubMed ID: 36336945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hub genes associated with head and neck squamous cell carcinoma by integrated bioinformatics approach and RNA-seq validation analysis.
    Shabeer A; Mustafa S; Bukhari RS; Abdel-Maksoud MA; Almutairi SM; Al-Qahtani WH; Chandio K; Khan NY; Gul J; Aufy M
    Am J Cancer Res; 2023; 13(4):1259-1277. PubMed ID: 37168331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis.
    Dai JJ; Zhou WB; Wang B
    Medicine (Baltimore); 2020 Oct; 99(44):e23052. PubMed ID: 33126397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key genes and biological pathways in lung adenocarcinoma by integrated bioinformatics analysis.
    Zhang L; Liu Y; Zhuang JG; Guo J; Li YT; Dong Y; Song G
    World J Clin Cases; 2023 Aug; 11(23):5504-5518. PubMed ID: 37637684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential key molecular biomarkers in lung adenocarcinoma by bioinformatics analysis.
    Guo P; Xu T; Jiang Y; Shen W
    Transl Cancer Res; 2022 Jan; 11(1):227-241. PubMed ID: 35261899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis.
    Wang H; Zhang Z; Xu K; Wei S; Li L; Wang L
    Oncol Lett; 2019 Nov; 18(5):4605-4612. PubMed ID: 31611968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.
    Liu X; Ren Y; Qin S; Yang Z
    BMC Complement Med Ther; 2024 May; 24(1):202. PubMed ID: 38783288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of promising candidate biomarkers in kidney renal clear cell carcinoma: evidence from the in-depth analysis of high-throughput data.
    Li X; Li M; Zhao T; Zhang J
    Am J Cancer Res; 2023; 13(9):4288-4304. PubMed ID: 37818073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer.
    Tang Q; Atiq W; Mahnoor S; Abdel-Maksoud MA; Aufy M; Yaz H; Zhu J
    Oncol Res; 2023; 31(2):141-156. PubMed ID: 37304238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.
    Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B
    World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.
    Zheng Q; Min S; Zhou Q
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34017995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma.
    Guo T; Ma H; Zhou Y
    PeerJ; 2019; 7():e7313. PubMed ID: 31333911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.
    Wang W; He J; Lu H; Kong Q; Lin S
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma.
    Cai W; Jing M; Wen J; Guo H; Xue Z
    Front Genet; 2022; 13():817552. PubMed ID: 35711943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.